nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.301	0.691	CbGbCtD
Acetaminophen—PTGS2—amyotrophic lateral sclerosis	0.233	1	CbGaD
Acetaminophen—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.135	0.309	CbGbCtD
Acetaminophen—TRPV1—spinal nerve—amyotrophic lateral sclerosis	0.0258	0.274	CbGeAlD
Acetaminophen—TRPV1—sciatic nerve—amyotrophic lateral sclerosis	0.0166	0.177	CbGeAlD
Acetaminophen—TRPV1—cranial nerve—amyotrophic lateral sclerosis	0.00969	0.103	CbGeAlD
Acetaminophen—Stridor—Riluzole—amyotrophic lateral sclerosis	0.00665	0.047	CcSEcCtD
Acetaminophen—Trismus—Riluzole—amyotrophic lateral sclerosis	0.00649	0.0459	CcSEcCtD
Acetaminophen—TRPV1—peripheral nervous system—amyotrophic lateral sclerosis	0.00637	0.0677	CbGeAlD
Acetaminophen—Traumatic liver injury—Riluzole—amyotrophic lateral sclerosis	0.00582	0.0411	CcSEcCtD
Acetaminophen—TRPV1—nerve—amyotrophic lateral sclerosis	0.00497	0.0528	CbGeAlD
Acetaminophen—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00435	0.0308	CcSEcCtD
Acetaminophen—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00435	0.0308	CcSEcCtD
Acetaminophen—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.00412	0.0291	CcSEcCtD
Acetaminophen—Enlargement abdomen—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0254	CcSEcCtD
Acetaminophen—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0036	0.0254	CcSEcCtD
Acetaminophen—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0203	CcSEcCtD
Acetaminophen—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00288	0.0203	CcSEcCtD
Acetaminophen—Pleural effusion—Riluzole—amyotrophic lateral sclerosis	0.00283	0.02	CcSEcCtD
Acetaminophen—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.00257	0.0182	CcSEcCtD
Acetaminophen—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00221	0.0156	CcSEcCtD
Acetaminophen—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0153	CcSEcCtD
Acetaminophen—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0152	CcSEcCtD
Acetaminophen—Coma—Riluzole—amyotrophic lateral sclerosis	0.00198	0.014	CcSEcCtD
Acetaminophen—Pulmonary oedema—Riluzole—amyotrophic lateral sclerosis	0.00193	0.0136	CcSEcCtD
Acetaminophen—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00186	0.0132	CcSEcCtD
Acetaminophen—Hepatic function abnormal—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0127	CcSEcCtD
Acetaminophen—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0127	CcSEcCtD
Acetaminophen—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00171	0.0181	CbGeAlD
Acetaminophen—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0118	CcSEcCtD
Acetaminophen—SULT2A1—nervous system—amyotrophic lateral sclerosis	0.0016	0.017	CbGeAlD
Acetaminophen—SULT2A1—central nervous system—amyotrophic lateral sclerosis	0.00154	0.0163	CbGeAlD
Acetaminophen—SULT1A1—spinal cord—amyotrophic lateral sclerosis	0.00151	0.016	CbGeAlD
Acetaminophen—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0106	CcSEcCtD
Acetaminophen—PTGS2—appendage—amyotrophic lateral sclerosis	0.00146	0.0155	CbGeAlD
Acetaminophen—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00143	0.0101	CcSEcCtD
Acetaminophen—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00142	0.01	CcSEcCtD
Acetaminophen—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00139	0.0098	CcSEcCtD
Acetaminophen—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00967	CcSEcCtD
Acetaminophen—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0096	CcSEcCtD
Acetaminophen—TRPV1—spinal cord—amyotrophic lateral sclerosis	0.00133	0.0141	CbGeAlD
Acetaminophen—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00921	CcSEcCtD
Acetaminophen—CNR1—cerebellum—amyotrophic lateral sclerosis	0.0013	0.0138	CbGeAlD
Acetaminophen—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00912	CcSEcCtD
Acetaminophen—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00898	CcSEcCtD
Acetaminophen—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.00127	0.00898	CcSEcCtD
Acetaminophen—SULT1A1—nervous system—amyotrophic lateral sclerosis	0.00127	0.0135	CbGeAlD
Acetaminophen—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00124	0.00877	CcSEcCtD
Acetaminophen—SULT1A1—central nervous system—amyotrophic lateral sclerosis	0.00122	0.013	CbGeAlD
Acetaminophen—SULT2A1—brain—amyotrophic lateral sclerosis	0.00122	0.013	CbGeAlD
Acetaminophen—SULT1A1—cerebellum—amyotrophic lateral sclerosis	0.00119	0.0127	CbGeAlD
Acetaminophen—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00821	CcSEcCtD
Acetaminophen—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00115	0.0081	CcSEcCtD
Acetaminophen—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00799	CcSEcCtD
Acetaminophen—TRPV1—nervous system—amyotrophic lateral sclerosis	0.00112	0.0119	CbGeAlD
Acetaminophen—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00773	CcSEcCtD
Acetaminophen—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00769	CcSEcCtD
Acetaminophen—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00769	CcSEcCtD
Acetaminophen—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00765	CcSEcCtD
Acetaminophen—TRPV1—central nervous system—amyotrophic lateral sclerosis	0.00108	0.0114	CbGeAlD
Acetaminophen—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00759	CcSEcCtD
Acetaminophen—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00757	CcSEcCtD
Acetaminophen—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00755	CcSEcCtD
Acetaminophen—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.00107	0.00753	CcSEcCtD
Acetaminophen—CNR1—brain—amyotrophic lateral sclerosis	0.00105	0.0112	CbGeAlD
Acetaminophen—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00103	0.00727	CcSEcCtD
Acetaminophen—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00718	CcSEcCtD
Acetaminophen—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00713	CcSEcCtD
Acetaminophen—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.000987	0.00697	CcSEcCtD
Acetaminophen—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.000983	0.00694	CcSEcCtD
Acetaminophen—Mediastinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000981	0.00693	CcSEcCtD
Acetaminophen—Chills—Riluzole—amyotrophic lateral sclerosis	0.000976	0.0069	CcSEcCtD
Acetaminophen—SULT1A1—brain—amyotrophic lateral sclerosis	0.00097	0.0103	CbGeAlD
Acetaminophen—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.000953	0.00673	CcSEcCtD
Acetaminophen—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000947	0.00669	CcSEcCtD
Acetaminophen—Tension—Riluzole—amyotrophic lateral sclerosis	0.000929	0.00657	CcSEcCtD
Acetaminophen—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00092	0.0065	CcSEcCtD
Acetaminophen—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000911	0.00643	CcSEcCtD
Acetaminophen—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000887	0.00627	CcSEcCtD
Acetaminophen—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000879	0.00621	CcSEcCtD
Acetaminophen—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000875	0.00618	CcSEcCtD
Acetaminophen—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00087	0.00615	CcSEcCtD
Acetaminophen—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000865	0.00611	CcSEcCtD
Acetaminophen—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000854	0.00603	CcSEcCtD
Acetaminophen—TRPV1—brain—amyotrophic lateral sclerosis	0.000854	0.00907	CbGeAlD
Acetaminophen—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000848	0.00599	CcSEcCtD
Acetaminophen—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000837	0.00591	CcSEcCtD
Acetaminophen—Cough—Riluzole—amyotrophic lateral sclerosis	0.000827	0.00584	CcSEcCtD
Acetaminophen—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000821	0.0058	CcSEcCtD
Acetaminophen—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000818	0.00578	CcSEcCtD
Acetaminophen—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.000806	0.0057	CcSEcCtD
Acetaminophen—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00568	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.000801	0.00566	CcSEcCtD
Acetaminophen—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000797	0.00563	CcSEcCtD
Acetaminophen—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000789	0.00557	CcSEcCtD
Acetaminophen—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000779	0.00551	CcSEcCtD
Acetaminophen—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00546	CcSEcCtD
Acetaminophen—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000773	0.00546	CcSEcCtD
Acetaminophen—Shock—Riluzole—amyotrophic lateral sclerosis	0.000761	0.00537	CcSEcCtD
Acetaminophen—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.000758	0.00536	CcSEcCtD
Acetaminophen—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000757	0.00535	CcSEcCtD
Acetaminophen—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000754	0.00533	CcSEcCtD
Acetaminophen—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000751	0.0053	CcSEcCtD
Acetaminophen—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000747	0.00528	CcSEcCtD
Acetaminophen—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000737	0.00521	CcSEcCtD
Acetaminophen—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000722	0.0051	CcSEcCtD
Acetaminophen—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000699	0.00494	CcSEcCtD
Acetaminophen—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000689	0.00487	CcSEcCtD
Acetaminophen—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000687	0.00485	CcSEcCtD
Acetaminophen—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00068	0.00481	CcSEcCtD
Acetaminophen—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000672	0.00475	CcSEcCtD
Acetaminophen—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000668	0.0071	CbGeAlD
Acetaminophen—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000667	0.00471	CcSEcCtD
Acetaminophen—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000666	0.00471	CcSEcCtD
Acetaminophen—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000661	0.00467	CcSEcCtD
Acetaminophen—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000637	0.0045	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000632	0.00447	CcSEcCtD
Acetaminophen—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000614	0.00434	CcSEcCtD
Acetaminophen—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000611	0.00432	CcSEcCtD
Acetaminophen—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000611	0.00432	CcSEcCtD
Acetaminophen—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00057	0.00402	CcSEcCtD
Acetaminophen—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000555	0.00392	CcSEcCtD
Acetaminophen—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000547	0.00386	CcSEcCtD
Acetaminophen—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00374	CcSEcCtD
Acetaminophen—SLC22A6—brain—amyotrophic lateral sclerosis	0.000525	0.00558	CbGeAlD
Acetaminophen—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000511	0.00361	CcSEcCtD
Acetaminophen—CYP2A6—cerebellum—amyotrophic lateral sclerosis	0.000504	0.00536	CbGeAlD
Acetaminophen—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000491	0.00347	CcSEcCtD
Acetaminophen—Rash—Riluzole—amyotrophic lateral sclerosis	0.000487	0.00344	CcSEcCtD
Acetaminophen—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000487	0.00344	CcSEcCtD
Acetaminophen—PTGS2—embryo—amyotrophic lateral sclerosis	0.000486	0.00516	CbGeAlD
Acetaminophen—Headache—Riluzole—amyotrophic lateral sclerosis	0.000484	0.00342	CcSEcCtD
Acetaminophen—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000459	0.00324	CcSEcCtD
Acetaminophen—CYP2A6—brain—amyotrophic lateral sclerosis	0.00041	0.00435	CbGeAlD
Acetaminophen—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000383	0.00407	CbGeAlD
Acetaminophen—CYP2E1—medulla oblongata—amyotrophic lateral sclerosis	0.000337	0.00358	CbGeAlD
Acetaminophen—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.00031	0.0033	CbGeAlD
Acetaminophen—CYP2E1—spinal cord—amyotrophic lateral sclerosis	0.000301	0.00319	CbGeAlD
Acetaminophen—ABCB1—embryo—amyotrophic lateral sclerosis	0.0003	0.00319	CbGeAlD
Acetaminophen—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.00029	0.00308	CbGeAlD
Acetaminophen—CYP1A1—nervous system—amyotrophic lateral sclerosis	0.000278	0.00295	CbGeAlD
Acetaminophen—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000277	0.00294	CbGeAlD
Acetaminophen—CYP1A1—central nervous system—amyotrophic lateral sclerosis	0.000267	0.00284	CbGeAlD
Acetaminophen—CYP2E1—nervous system—amyotrophic lateral sclerosis	0.000253	0.00269	CbGeAlD
Acetaminophen—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000244	0.00259	CbGeAlD
Acetaminophen—CYP2E1—central nervous system—amyotrophic lateral sclerosis	0.000244	0.00259	CbGeAlD
Acetaminophen—CYP2E1—cerebellum—amyotrophic lateral sclerosis	0.000238	0.00253	CbGeAlD
Acetaminophen—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000235	0.0025	CbGeAlD
Acetaminophen—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000233	0.00248	CbGeAlD
Acetaminophen—CYP2C8—brain—amyotrophic lateral sclerosis	0.00023	0.00244	CbGeAlD
Acetaminophen—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000225	0.00239	CbGeAlD
Acetaminophen—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000219	0.00233	CbGeAlD
Acetaminophen—CYP1A1—brain—amyotrophic lateral sclerosis	0.000212	0.00226	CbGeAlD
Acetaminophen—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000204	0.00217	CbGeAlD
Acetaminophen—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000201	0.00213	CbGeAlD
Acetaminophen—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000196	0.00209	CbGeAlD
Acetaminophen—CYP2E1—brain—amyotrophic lateral sclerosis	0.000194	0.00206	CbGeAlD
Acetaminophen—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000193	0.00205	CbGeAlD
Acetaminophen—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000192	0.00204	CbGeAlD
Acetaminophen—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000189	0.00201	CbGeAlD
Acetaminophen—PTGS1—brain—amyotrophic lateral sclerosis	0.000187	0.00198	CbGeAlD
Acetaminophen—PTGS2—brain—amyotrophic lateral sclerosis	0.000178	0.00189	CbGeAlD
Acetaminophen—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000171	0.00182	CbGeAlD
Acetaminophen—CYP2D6—brain—amyotrophic lateral sclerosis	0.000153	0.00163	CbGeAlD
Acetaminophen—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000144	0.00153	CbGeAlD
Acetaminophen—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000139	0.00148	CbGeAlD
Acetaminophen—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000136	0.00144	CbGeAlD
Acetaminophen—ABCB1—brain—amyotrophic lateral sclerosis	0.00011	0.00117	CbGeAlD
Acetaminophen—SULT2A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.72e-05	0.000495	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—APOE—amyotrophic lateral sclerosis	4.71e-05	0.000494	CbGpPWpGaD
Acetaminophen—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.67e-05	0.00049	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.61e-05	0.000484	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.6e-05	0.000483	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.57e-05	0.00048	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.55e-05	0.000477	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	4.54e-05	0.000477	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	4.54e-05	0.000477	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.5e-05	0.000472	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	4.44e-05	0.000466	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.41e-05	0.000463	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.34e-05	0.000455	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	4.34e-05	0.000455	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.33e-05	0.000454	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.28e-05	0.000449	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.28e-05	0.000449	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	4.24e-05	0.000444	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.23e-05	0.000444	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	4.16e-05	0.000437	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	4.15e-05	0.000436	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	4.14e-05	0.000435	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	4.14e-05	0.000434	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.14e-05	0.000434	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.03e-05	0.000423	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.03e-05	0.000423	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.97e-05	0.000416	CbGpPWpGaD
Acetaminophen—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.96e-05	0.000415	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.93e-05	0.000413	CbGpPWpGaD
Acetaminophen—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.93e-05	0.000412	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—DAO—amyotrophic lateral sclerosis	3.91e-05	0.00041	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.91e-05	0.00041	CbGpPWpGaD
Acetaminophen—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.91e-05	0.00041	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.89e-05	0.000408	CbGpPWpGaD
Acetaminophen—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.87e-05	0.000406	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.86e-05	0.000405	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	3.85e-05	0.000404	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.85e-05	0.000403	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PLB1—amyotrophic lateral sclerosis	3.85e-05	0.000403	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	3.77e-05	0.000395	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.76e-05	0.000394	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.72e-05	0.00039	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.7e-05	0.000388	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	3.7e-05	0.000388	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	3.7e-05	0.000388	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.69e-05	0.000387	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.69e-05	0.000387	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	3.64e-05	0.000382	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.64e-05	0.000381	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.63e-05	0.000381	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—APOE—amyotrophic lateral sclerosis	3.57e-05	0.000374	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.55e-05	0.000373	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	3.55e-05	0.000372	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—GSR—amyotrophic lateral sclerosis	3.55e-05	0.000372	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.53e-05	0.000371	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.45e-05	0.000362	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.43e-05	0.00036	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.42e-05	0.000359	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	3.41e-05	0.000357	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—APOE—amyotrophic lateral sclerosis	3.4e-05	0.000357	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.4e-05	0.000356	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	3.38e-05	0.000355	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.36e-05	0.000352	CbGpPWpGaD
Acetaminophen—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.35e-05	0.000352	CbGpPWpGaD
Acetaminophen—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.31e-05	0.000347	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	3.29e-05	0.000345	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	3.28e-05	0.000345	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.25e-05	0.000341	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.23e-05	0.000339	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.23e-05	0.000338	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.22e-05	0.000338	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.22e-05	0.000338	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.22e-05	0.000338	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—APOE—amyotrophic lateral sclerosis	3.2e-05	0.000336	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	3.2e-05	0.000335	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.19e-05	0.000335	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.16e-05	0.000332	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.14e-05	0.00033	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.13e-05	0.000329	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—DAO—amyotrophic lateral sclerosis	3.09e-05	0.000324	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.03e-05	0.000318	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.03e-05	0.000318	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	3.01e-05	0.000316	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	3.01e-05	0.000316	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	2.97e-05	0.000312	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.96e-05	0.000311	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.95e-05	0.00031	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	2.94e-05	0.000309	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.91e-05	0.000306	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.91e-05	0.000306	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—CHAT—amyotrophic lateral sclerosis	2.91e-05	0.000306	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	2.89e-05	0.000304	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.85e-05	0.0003	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.85e-05	0.0003	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.84e-05	0.000298	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.82e-05	0.000296	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.8e-05	0.000294	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.78e-05	0.000291	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.75e-05	0.000289	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.74e-05	0.000287	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GSR—amyotrophic lateral sclerosis	2.74e-05	0.000287	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.67e-05	0.00028	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—APOE—amyotrophic lateral sclerosis	2.67e-05	0.00028	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.66e-05	0.000279	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	2.65e-05	0.000278	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.63e-05	0.000276	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.63e-05	0.000276	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.62e-05	0.000275	CbGpPWpGaD
Acetaminophen—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.59e-05	0.000272	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.58e-05	0.000271	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.57e-05	0.00027	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.57e-05	0.00027	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.57e-05	0.00027	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.56e-05	0.000268	CbGpPWpGaD
Acetaminophen—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.55e-05	0.000268	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.54e-05	0.000267	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.49e-05	0.000261	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	2.47e-05	0.000259	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.44e-05	0.000256	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.43e-05	0.000254	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.41e-05	0.000253	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.4e-05	0.000252	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.4e-05	0.000251	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.38e-05	0.000249	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.35e-05	0.000247	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.34e-05	0.000246	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.33e-05	0.000245	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.33e-05	0.000244	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	2.3e-05	0.000241	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.25e-05	0.000236	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.22e-05	0.000233	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.21e-05	0.000232	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	2.19e-05	0.00023	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.19e-05	0.00023	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.19e-05	0.000229	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.17e-05	0.000228	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.17e-05	0.000228	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.17e-05	0.000227	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSR—amyotrophic lateral sclerosis	2.16e-05	0.000227	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.09e-05	0.000219	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.05e-05	0.000216	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.04e-05	0.000214	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	2.02e-05	0.000212	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2e-05	0.00021	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.98e-05	0.000208	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.98e-05	0.000208	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	1.9e-05	0.000199	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.89e-05	0.000198	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.87e-05	0.000196	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.86e-05	0.000195	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.86e-05	0.000195	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.86e-05	0.000195	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.83e-05	0.000192	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.82e-05	0.000191	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.81e-05	0.00019	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.78e-05	0.000186	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.76e-05	0.000185	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.72e-05	0.000181	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.7e-05	0.000179	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.69e-05	0.000177	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.68e-05	0.000176	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.67e-05	0.000176	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.67e-05	0.000175	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.66e-05	0.000174	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.65e-05	0.000173	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.63e-05	0.000171	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.59e-05	0.000166	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.58e-05	0.000166	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.58e-05	0.000165	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.57e-05	0.000164	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.57e-05	0.000164	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.53e-05	0.000161	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.53e-05	0.000161	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.53e-05	0.00016	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.52e-05	0.00016	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.49e-05	0.000156	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000151	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.44e-05	0.000151	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.43e-05	0.00015	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.42e-05	0.000149	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.41e-05	0.000148	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.4e-05	0.000147	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.39e-05	0.000145	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	1.38e-05	0.000145	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.34e-05	0.00014	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.3e-05	0.000136	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.28e-05	0.000134	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.26e-05	0.000132	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.25e-05	0.000131	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.21e-05	0.000127	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.19e-05	0.000125	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000124	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000124	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.18e-05	0.000124	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	1.18e-05	0.000124	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.17e-05	0.000123	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.14e-05	0.00012	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	0.000116	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.09e-05	0.000114	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.07e-05	0.000112	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.07e-05	0.000112	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.05e-05	0.00011	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.01e-05	0.000106	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1e-05	0.000105	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.74e-06	0.000102	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	9.65e-06	0.000101	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.59e-06	0.000101	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.54e-06	0.0001	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.32e-06	9.77e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	9.15e-06	9.6e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—APOE—amyotrophic lateral sclerosis	9.13e-06	9.58e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9e-06	9.44e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.77e-06	9.2e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.27e-06	8.67e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.25e-06	8.65e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	8.24e-06	8.64e-05	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.11e-06	8.51e-05	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.11e-06	8.51e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.81e-06	8.19e-05	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	7.66e-06	8.04e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.58e-06	7.95e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—APOE—amyotrophic lateral sclerosis	7.21e-06	7.57e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.19e-06	7.54e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	6.8e-06	7.14e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.77e-06	7.1e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.71e-06	7.04e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.67e-06	7e-05	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.62e-06	6.94e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.6e-06	6.93e-05	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.26e-06	6.56e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	6.24e-06	6.54e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.22e-06	6.53e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.17e-06	6.47e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.74e-06	6.02e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	5.43e-06	5.7e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.27e-06	5.53e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	5.12e-06	5.37e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	5.08e-06	5.33e-05	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.94e-06	5.19e-05	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.66e-06	4.89e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.43e-06	4.65e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	4.34e-06	4.55e-05	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.27e-06	4.48e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.07e-06	4.27e-05	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.72e-06	3.91e-05	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.51e-06	3.68e-05	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.48e-06	3.65e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.35e-06	3.51e-05	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.97e-06	3.12e-05	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.29e-06	2.41e-05	CbGpPWpGaD
